Last update 21 Nov 2024
Acyclovir/Hydrocortisone
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Xerclear |
Mechanism DNA-directed DNA polymerase inhibitors, GR agonists(Glucocorticoid receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (31 Jul 2009), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC29H41N5O8 |
InChIKeyMDCGTBRYRLWFJI-WDCKKOMHSA-N |
CAS Registry439279-66-0 |
Related
6
Clinical Trials associated with Acyclovir/HydrocortisoneAn Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
A Randomized, Double-Blind, Active-Controlled, Subject Initiated Study Comparing ME-609 to Acyclovir Cream for Treatment of Recurrent Herpes Simplex Labialis in Immunocompromised Patients
An open label, multi-centre, phase III, subject initiated safety study of ME-609 in treatment of recurrent herpes simplex labialis in adolescents.
100 Clinical Results associated with Acyclovir/Hydrocortisone
Login to view more data
100 Translational Medicine associated with Acyclovir/Hydrocortisone
Login to view more data
100 Patents (Medical) associated with Acyclovir/Hydrocortisone
Login to view more data
100 Deals associated with Acyclovir/Hydrocortisone
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Herpes Labialis | US | 31 Jul 2009 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Herpes Labialis | Discovery | KR | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | 2,437 | ncthrwzmxd(wjcchvplgt) = qwnjjpzoup cfwhmmuscx (cyjoxzdjcs ) | Positive | 01 Apr 2011 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free